相关实验视频

Updated: Jun 29, 2025

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.2K

针对抗病毒开发的向蛋白酶的最新进展

Pedro Henrique Oliveira Borges1,2, Sabrina Baptista Ferreira1, Floriano Paes Silva2

  • 1Laboratory of Organic Synthesis and Biological Prospecting, Chemistry Institute, Federal University of Rio de Janeiro, Rio de Janeiro 21941-909, Brazil.

Viruses
|March 28, 2024
PubMed
概括

病毒蛋白酶是新抗病毒药物的关键标. 本综述探讨了抑制剂和分子策略,包括蛋白质降解,以对抗病毒感染和耐药性.

关键词:
这就是 PROTACs.抗病毒疗法 抗病毒疗法同价抑制剂是共价抑制剂.自然产品是自然产品的产品.类模仿药物是什么?病毒蛋白酶是一种病毒蛋白酶.

更多相关视频

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1000
Assays for the Identification of Novel Antivirals against Bluetongue Virus12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.1K

相关概念视频

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.9K